Advances in Risk-Stratification and Therapeutic Options for Early-Stage Non–Small Cell Lung Cancer

EP. 1: Advances in Risk-Stratification and Therapeutic Options for Early-Stage Non–Small Cell Lung Cancer

October 12th 2021

EP. 2: Dr. Bordoni on the Utility of Adjuvant Osimertinib in ​EGFR-Mutant Lung Cancer

November 10th 2021

Rodolfo Bordoni, MD, discusses the utility of ​adjuvant osimertinib in lung cancer.

EP. 3: Dr. Lazar on Risk Stratification for Chemotherapy and Adjuvant Therapy in Lung Cancer

November 10th 2021

John F. Lazar, MD, discusses risk stratification for chemotherapy and adjuvant therapy in lung cancer.

EP. 4: Dr. Langer on the Need for Reflex Testing in NSCLC

November 10th 2021

Corey J. Langer, MD, discusses the need for reflex testing in patients with non–small cell lung cancer.